menu search

Atea pharmaceuticals to host third quarter 2023 financial results conference call on november 8, 2023

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-s...

November 1, 2023, 7:00 am

Affimed to participate in upcoming investor conferences

MANNHEIM, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-...

November 1, 2023, 6:30 am

Dax index: the us labor market to take center stage pre-fed

The DAX benefitted from corporate earnings results on Tuesday. However, US economic indicators could test the appetite for riskier assets late in the ...

November 1, 2023, 5:12 am

Scancell melanoma trial data chosen for poster presentation at sitc

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first ...

November 1, 2023, 4:16 am

Astrazeneca signs drug development deal with biotech cellectis

AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage...

November 1, 2023, 3:17 am

Aud to usd forecast: the chinese economy, the us labor market, and the fed in focus

The AUD’s fate hangs in the balance as the Chinese manufacturing , the US labor market, and the Fed take center ...

November 1, 2023, 12:13 am

Apnimed announces launch of joint venture with shionogi to develop novel pharmacologic therapies for obstructive sleep apnea and other sleep disorders

$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep dis...

November 1, 2023, 12:00 am

Lirum therapeutics presents positive data on lx-101, a novel clinical-stage targeted therapy, demonstrating potent preclinical activity against pediatric sarcomas

New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-...

October 31, 2023, 5:27 pm

Mersana therapeutics to host third quarter 2023 conference call on november 7, 2023

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stag...

October 31, 2023, 4:30 pm

Revolution medicines to report financial results for third quarter 2023 after market close on november 6, 2023

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-...

October 31, 2023, 4:15 pm

A generational opportunity for tellurian

Tellurian is a development stage LNG and natural gas producer aiming to sell low-cost US natural gas in...

October 31, 2023, 3:33 pm

Mining giant bhp commits $4.9b to expand jansen potash project in saskatchewan

(Kitco News) - Global mining and metals group BHP (ASX: BHP) announced on Tuesday that the company has approved an investment of US$4.9 billion (C$6.4...

October 31, 2023, 2:55 pm

The bitcoin white paper is now officially 15 years old

Bitcoin marked the first time money could be sent over the web without any intermediaries. A novel economic asset on the world ...

October 31, 2023, 1:59 pm

Amicus therapeutics: the right play now

Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rar...

October 31, 2023, 12:24 pm

A trick or a treat from bank of japan: indirect way of scrapping ycc

BoJ has subtly removed the 1% “hard-capped” upper limit of the 10-year JGB yield which suggests an imminent end to YCC may come sooner than expect...

October 31, 2023, 12:03 pm

Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3

Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) — Verve Thera...

October 31, 2023, 10:01 am

Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage...

October 31, 2023, 9:15 am

Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-...

October 31, 2023, 8:50 am

Apple's new lineup of chips will set the stage for future macs, says six colors' dan moren

Dan Moren, East Coast Bureau Chief at Six Colors, discusses Apple's new lineup of Macs....

October 31, 2023, 7:42 am

Alternative protein global investment leader big idea ventures announces first new protein fund ii singapore cohort

SINGAPORE, Oct. 30, 2023 (GLOBE NEWSWIRE) — Big Idea Ventures, a global leader investing in alternative protein and food technology, announced its f...

October 31, 2023, 1:00 am


Search within

Pages Search Results: